Evidence map›Paper›PMID 34388112›Full record

ArticleAging2021

Establishing a three-miRNA signature as a prognostic model for colorectal cancer through bioinformatics analysis.

Yiming Wang, Lumi Huang, Nan Shan, Huiwen Ma, Songmei Lu, Xingyue Chen, Hao Long

Open access · hybridAbstract read
In one paragraph

Article in Aging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. LncRNA FAM30A Predicts Adverse Prognosis and Regulates Cellular Processes in Colorectal Cancer via Modulating miR-21-3p.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Yiming WangDepartment of Medical Oncology, Chongqing University Cancer Hospital, Chongqing, China.
Lumi HuangDepartment of Medical Oncology, Chongqing University Cancer Hospital, Chongqing, China.
Nan ShanDepartment of Gynaecology and Obstetrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Huiwen MaDepartment of Medical Oncology, Chongqing University Cancer Hospital, Chongqing, China.
Songmei LuDepartment of Medical Oncology, Chongqing University Cancer Hospital, Chongqing, China.
Xingyue ChenDepartment of Medical Oncology, Chongqing University Cancer Hospital, Chongqing, China.
Hao LongDepartment of Palliative Care, Chongqing University Cancer Hospital, Chongqing, China.
Chongqing Cancer Hospital · CNChongqing University · CNFirst Affiliated Hospital of Chongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIdentification of more promising microRNAs (miRNAs) are being extensively studied with respect to colorectal cancer (CRC), since CRC is the leading cause of cancer deaths and most common malignant tumors worldwide. A series of colon cancer (CCa) samples from The Cancer Genome Atlas (TCGA) were analyzed to provide a new perspective into this field.

methodsThe expression of miRNAs, mRNAs and the clinical data of 437 CRC patients were downloaded from the TCGA database. The survival-related differentially expressed miRNAs (sDMIRs) and mRNAs were detected by COX regression analysis. The high-risk group and low-risk group were separated by the median risk score of the risk score model. The potential clinical characteristics of these sDMIRs were analyzed by R software. The potential molecular mechanisms of these sDMIRs were explored by computational biology. The expression levels of three sDMIRs were explored by qPCR in CRC samples.

resultsThree DMIRs (hsa-miR-21-3p, hsa-miR-194-3p and hsa-miR-891a-5p) correlated with the most remarkable prognostic values of CRC patients were selected to establish the risk score model (RSM) by univariate and multivariate COX regression analysis and the survival probability of the low-risk group was longer than that in the high-risk group. We detected the target genes of three sDMIRs and the potential molecular mechanisms of these sDMIRs. We further verified the high expression levels of hsa-miR-21-3p and hsa-miR-194-3p were associated with the early T-stages, while hsa-miR-891a-5p illustrated the reversed result.

conclusionOur study demonstrated three sDMIRs with significantly clinical values illustrated the potential predicting values in the prognosis of CRC patients. Our results may provide a new perspective for the diagnostic methods and treatment strategies in CRC patients.

Indexed as

Biomarkers, TumorColorectal NeoplasmsComputational BiologyDatasets as TopicFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMaleMicroRNAsPrognosisRisk AssessmentROC CurveSurvival RateBiomarkers, TumorMicroRNAsMIRN194 microRNA, humanMIRN21 microRNA, humanCCamiRNAprognostic modelrisk score

Identifiers

PMID34388112
PMCPMC8386531
OpenAlexW3191629161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.